Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pericardium | 4 | 2015 | 679 | 1.120 |
Why?
|
Heart-Assist Devices | 7 | 2020 | 1292 | 1.050 |
Why?
|
Aortic Valve | 6 | 2018 | 1969 | 0.950 |
Why?
|
Myocardium | 16 | 2022 | 4790 | 0.930 |
Why?
|
Heart Neoplasms | 5 | 2023 | 374 | 0.840 |
Why?
|
Autopsy | 15 | 2024 | 1013 | 0.840 |
Why?
|
Aorta | 5 | 2021 | 2046 | 0.830 |
Why?
|
Thrombosis | 6 | 2020 | 2956 | 0.800 |
Why?
|
Myocarditis | 7 | 2023 | 803 | 0.790 |
Why?
|
Endocarditis, Bacterial | 3 | 2019 | 436 | 0.690 |
Why?
|
Temporal Arteries | 2 | 2019 | 155 | 0.680 |
Why?
|
Extracellular Matrix | 6 | 2014 | 1739 | 0.660 |
Why?
|
Giant Cell Arteritis | 3 | 2019 | 307 | 0.630 |
Why?
|
Heart Diseases | 5 | 2022 | 2819 | 0.620 |
Why?
|
Drug Carriers | 8 | 2018 | 710 | 0.610 |
Why?
|
Herpesvirus 3, Human | 1 | 2019 | 159 | 0.590 |
Why?
|
Paclitaxel | 9 | 2020 | 1735 | 0.590 |
Why?
|
Mitral Valve | 3 | 2017 | 1475 | 0.580 |
Why?
|
Biocompatible Materials | 16 | 2015 | 1703 | 0.570 |
Why?
|
Sarcoidosis | 6 | 2023 | 535 | 0.570 |
Why?
|
Heart Defects, Congenital | 7 | 2018 | 4711 | 0.570 |
Why?
|
Mesothelioma | 8 | 2023 | 811 | 0.540 |
Why?
|
Heart Valve Diseases | 3 | 2018 | 1030 | 0.530 |
Why?
|
Leukemia, Myelomonocytic, Chronic | 1 | 2017 | 93 | 0.530 |
Why?
|
Nanoparticles | 10 | 2020 | 1989 | 0.520 |
Why?
|
Cardiomyopathies | 12 | 2023 | 2057 | 0.510 |
Why?
|
Lung Neoplasms | 28 | 2024 | 13593 | 0.500 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2019 | 1048 | 0.490 |
Why?
|
Heart | 9 | 2022 | 4448 | 0.490 |
Why?
|
Heart Transplantation | 13 | 2019 | 3301 | 0.480 |
Why?
|
Bupivacaine | 5 | 2014 | 413 | 0.470 |
Why?
|
Tissue Fixation | 1 | 2015 | 245 | 0.470 |
Why?
|
Intestinal Mucosa | 3 | 2014 | 3047 | 0.470 |
Why?
|
Cardiovascular Surgical Procedures | 1 | 2015 | 193 | 0.460 |
Why?
|
Antineoplastic Agents, Phytogenic | 6 | 2018 | 622 | 0.450 |
Why?
|
T-Lymphocytes | 7 | 2019 | 10276 | 0.450 |
Why?
|
Sciatic Nerve | 6 | 2014 | 628 | 0.440 |
Why?
|
Aortic Diseases | 2 | 2018 | 741 | 0.440 |
Why?
|
Heart Ventricles | 5 | 2019 | 3840 | 0.420 |
Why?
|
Wolff-Parkinson-White Syndrome | 1 | 2013 | 117 | 0.410 |
Why?
|
Cardiology | 3 | 2021 | 1701 | 0.400 |
Why?
|
Polymers | 12 | 2018 | 1632 | 0.400 |
Why?
|
Lymphocyte Activation | 6 | 2019 | 5505 | 0.390 |
Why?
|
Pleural Neoplasms | 4 | 2023 | 612 | 0.390 |
Why?
|
Connective Tissue Diseases | 1 | 2015 | 285 | 0.390 |
Why?
|
Lung Diseases | 2 | 2015 | 1943 | 0.370 |
Why?
|
Immunity, Cellular | 1 | 2017 | 1560 | 0.370 |
Why?
|
Cardiac Surgical Procedures | 3 | 2017 | 3683 | 0.360 |
Why?
|
Coronavirus Infections | 4 | 2020 | 3116 | 0.360 |
Why?
|
Biopsy | 12 | 2023 | 6805 | 0.350 |
Why?
|
Bioprosthesis | 4 | 2017 | 593 | 0.350 |
Why?
|
Pneumonia, Viral | 4 | 2020 | 3239 | 0.350 |
Why?
|
Transforming Growth Factor beta1 | 3 | 2024 | 642 | 0.350 |
Why?
|
Tetralogy of Fallot | 1 | 2016 | 628 | 0.350 |
Why?
|
Heart Valve Prosthesis | 6 | 2017 | 1468 | 0.340 |
Why?
|
Amyloid Neuropathies, Familial | 3 | 2018 | 180 | 0.340 |
Why?
|
Bone Morphogenetic Protein 2 | 5 | 2022 | 344 | 0.330 |
Why?
|
Prosthesis-Related Infections | 3 | 2013 | 497 | 0.320 |
Why?
|
Lung | 16 | 2024 | 10097 | 0.310 |
Why?
|
Coated Materials, Biocompatible | 4 | 2016 | 311 | 0.310 |
Why?
|
Animals | 98 | 2024 | 169408 | 0.300 |
Why?
|
Mycotoxins | 1 | 2008 | 35 | 0.300 |
Why?
|
Device Removal | 3 | 2018 | 643 | 0.300 |
Why?
|
Fatal Outcome | 7 | 2020 | 1836 | 0.300 |
Why?
|
Humans | 145 | 2024 | 768887 | 0.300 |
Why?
|
Anesthetics, Local | 4 | 2014 | 1004 | 0.290 |
Why?
|
Prosthesis Failure | 4 | 2017 | 1209 | 0.290 |
Why?
|
Bone Regeneration | 3 | 2022 | 446 | 0.290 |
Why?
|
Biofilms | 2 | 2016 | 634 | 0.290 |
Why?
|
Anesthesia, Local | 2 | 2006 | 279 | 0.280 |
Why?
|
Pulmonary Artery | 4 | 2024 | 1945 | 0.280 |
Why?
|
Biological Specimen Banks | 3 | 2022 | 789 | 0.280 |
Why?
|
Delayed-Action Preparations | 3 | 2022 | 969 | 0.280 |
Why?
|
Amyloidosis | 3 | 2022 | 879 | 0.280 |
Why?
|
Mannose-Binding Lectins | 1 | 2007 | 101 | 0.280 |
Why?
|
Fluorodeoxyglucose F18 | 5 | 2021 | 2056 | 0.270 |
Why?
|
Nerve Block | 4 | 2008 | 716 | 0.270 |
Why?
|
Cardiomyopathy, Dilated | 4 | 2017 | 843 | 0.270 |
Why?
|
Fibroblasts | 5 | 2024 | 4178 | 0.270 |
Why?
|
Tissue Engineering | 11 | 2016 | 1893 | 0.270 |
Why?
|
Male | 88 | 2024 | 365249 | 0.260 |
Why?
|
Prostheses and Implants | 6 | 2022 | 1279 | 0.260 |
Why?
|
Tetrodotoxin | 1 | 2006 | 245 | 0.250 |
Why?
|
Foreign-Body Reaction | 4 | 2017 | 156 | 0.250 |
Why?
|
Heart Failure | 5 | 2018 | 11879 | 0.250 |
Why?
|
Cattle | 14 | 2022 | 3820 | 0.250 |
Why?
|
Drug Delivery Systems | 7 | 2018 | 2238 | 0.250 |
Why?
|
Histiocytosis, Langerhans-Cell | 1 | 2007 | 171 | 0.250 |
Why?
|
Graft Rejection | 7 | 2015 | 4492 | 0.240 |
Why?
|
Heart Valve Prosthesis Implantation | 6 | 2018 | 1568 | 0.240 |
Why?
|
Pulmonary Valve Insufficiency | 2 | 2018 | 140 | 0.230 |
Why?
|
Leukemia Inhibitory Factor | 1 | 2024 | 81 | 0.230 |
Why?
|
Mice | 61 | 2024 | 82074 | 0.230 |
Why?
|
Myofibroblasts | 3 | 2024 | 230 | 0.230 |
Why?
|
Lectins, C-Type | 1 | 2007 | 593 | 0.220 |
Why?
|
Heart, Artificial | 2 | 2013 | 110 | 0.220 |
Why?
|
Giant Cells | 2 | 2021 | 187 | 0.210 |
Why?
|
Ovarian Neoplasms | 4 | 2013 | 4919 | 0.210 |
Why?
|
Receptors, Glucocorticoid | 1 | 2024 | 309 | 0.200 |
Why?
|
Female | 69 | 2024 | 397464 | 0.200 |
Why?
|
Interleukin-13 | 1 | 2024 | 391 | 0.200 |
Why?
|
Cryopreservation | 2 | 2020 | 733 | 0.200 |
Why?
|
Aged | 41 | 2024 | 171790 | 0.200 |
Why?
|
Middle Aged | 48 | 2024 | 223740 | 0.200 |
Why?
|
B-Lymphocyte Subsets | 1 | 2023 | 241 | 0.190 |
Why?
|
Matrix Metalloproteinase 8 | 1 | 2021 | 57 | 0.190 |
Why?
|
Rats, Sprague-Dawley | 15 | 2021 | 8200 | 0.190 |
Why?
|
Pneumonectomy | 3 | 2024 | 1159 | 0.190 |
Why?
|
Synovial Membrane | 1 | 2024 | 536 | 0.190 |
Why?
|
Membranes, Artificial | 2 | 2009 | 367 | 0.190 |
Why?
|
Rats | 20 | 2022 | 23847 | 0.190 |
Why?
|
Pulmonary Valve | 2 | 2018 | 413 | 0.190 |
Why?
|
Signal Transduction | 11 | 2024 | 23652 | 0.180 |
Why?
|
Lung Transplantation | 3 | 2015 | 1309 | 0.180 |
Why?
|
Positron-Emission Tomography | 7 | 2021 | 6673 | 0.180 |
Why?
|
Materials Testing | 11 | 2014 | 873 | 0.180 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 1 | 2024 | 271 | 0.180 |
Why?
|
Thymus Neoplasms | 1 | 2023 | 277 | 0.180 |
Why?
|
Cartilage, Articular | 4 | 2018 | 1104 | 0.170 |
Why?
|
Wettability | 1 | 2019 | 27 | 0.170 |
Why?
|
Adhesiveness | 1 | 2019 | 52 | 0.170 |
Why?
|
Procollagen-Proline Dioxygenase | 2 | 2010 | 81 | 0.170 |
Why?
|
Adenocarcinoma, Bronchiolo-Alveolar | 4 | 2007 | 89 | 0.170 |
Why?
|
Aged, 80 and over | 23 | 2024 | 59738 | 0.170 |
Why?
|
Cartilage | 5 | 2008 | 811 | 0.170 |
Why?
|
Amyloidogenic Proteins | 2 | 2022 | 154 | 0.170 |
Why?
|
Cause of Death | 4 | 2024 | 3721 | 0.170 |
Why?
|
Muscle, Skeletal | 3 | 2021 | 4980 | 0.160 |
Why?
|
Echocardiography, Transesophageal | 3 | 2017 | 1096 | 0.160 |
Why?
|
Incidental Findings | 1 | 2024 | 697 | 0.160 |
Why?
|
Severe Acute Respiratory Syndrome | 1 | 2020 | 136 | 0.160 |
Why?
|
Adhesives | 1 | 2019 | 67 | 0.160 |
Why?
|
HSP90 Heat-Shock Proteins | 3 | 2012 | 423 | 0.160 |
Why?
|
Polyglactin 910 | 2 | 2014 | 56 | 0.160 |
Why?
|
Magnetic Resonance Imaging, Cine | 2 | 2019 | 1092 | 0.160 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 1999 | 196 | 0.160 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2022 | 4413 | 0.160 |
Why?
|
Antiphospholipid Syndrome | 1 | 2020 | 167 | 0.160 |
Why?
|
Hydrogen | 1 | 2019 | 171 | 0.160 |
Why?
|
Carcinoma | 3 | 2018 | 2340 | 0.160 |
Why?
|
Neovascularization, Physiologic | 3 | 2013 | 1371 | 0.160 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 5 | 2011 | 1769 | 0.160 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2024 | 522 | 0.160 |
Why?
|
Hyaluronic Acid | 3 | 2015 | 488 | 0.160 |
Why?
|
Absorbable Implants | 4 | 2014 | 338 | 0.150 |
Why?
|
Esophageal Fistula | 1 | 2018 | 60 | 0.150 |
Why?
|
Paraffin Embedding | 1 | 2019 | 306 | 0.150 |
Why?
|
Fibrosis | 4 | 2023 | 2081 | 0.150 |
Why?
|
Receptors, Somatostatin | 1 | 2019 | 138 | 0.150 |
Why?
|
Plaque, Amyloid | 1 | 2022 | 769 | 0.150 |
Why?
|
Prealbumin | 2 | 2022 | 259 | 0.150 |
Why?
|
Mutation | 14 | 2023 | 30266 | 0.150 |
Why?
|
Lymph Nodes | 2 | 2024 | 3473 | 0.150 |
Why?
|
Ablation Techniques | 1 | 2021 | 255 | 0.150 |
Why?
|
Calcinosis | 3 | 2017 | 1481 | 0.150 |
Why?
|
Glucuronidase | 1 | 2019 | 205 | 0.150 |
Why?
|
Femoral Vein | 1 | 2018 | 155 | 0.150 |
Why?
|
Shock, Cardiogenic | 2 | 2013 | 711 | 0.150 |
Why?
|
Germinal Center | 1 | 2020 | 380 | 0.140 |
Why?
|
Adipocytes | 1 | 2024 | 1199 | 0.140 |
Why?
|
Tachycardia, Ventricular | 3 | 2023 | 1309 | 0.140 |
Why?
|
Young Adult | 15 | 2024 | 60110 | 0.140 |
Why?
|
Transplantation, Homologous | 5 | 2013 | 4835 | 0.140 |
Why?
|
Adult | 35 | 2024 | 223818 | 0.140 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 1999 | 594 | 0.140 |
Why?
|
Peripheral Nerves | 1 | 2021 | 492 | 0.140 |
Why?
|
Antigens, CD | 2 | 2007 | 4032 | 0.140 |
Why?
|
Neoplasms | 5 | 2019 | 22390 | 0.140 |
Why?
|
Virus Internalization | 1 | 2021 | 503 | 0.140 |
Why?
|
Peritoneal Neoplasms | 2 | 2016 | 714 | 0.140 |
Why?
|
Polyethylene Glycols | 6 | 2018 | 1197 | 0.140 |
Why?
|
Bone and Bones | 5 | 2016 | 2589 | 0.140 |
Why?
|
Dilatation, Pathologic | 1 | 2018 | 527 | 0.140 |
Why?
|
Radiopharmaceuticals | 5 | 2021 | 2734 | 0.140 |
Why?
|
Adenocarcinoma | 7 | 2010 | 6401 | 0.140 |
Why?
|
Glycoproteins | 3 | 2015 | 2202 | 0.140 |
Why?
|
DNA, Bacterial | 2 | 2019 | 1478 | 0.140 |
Why?
|
Actins | 3 | 2012 | 2065 | 0.130 |
Why?
|
Hydrocortisone | 1 | 2024 | 1842 | 0.130 |
Why?
|
Chest Pain | 2 | 2013 | 1101 | 0.130 |
Why?
|
Osteogenesis | 4 | 2022 | 1295 | 0.130 |
Why?
|
Cell Survival | 8 | 2020 | 5794 | 0.130 |
Why?
|
Prosthesis Design | 3 | 2018 | 2126 | 0.130 |
Why?
|
Cell Line, Tumor | 17 | 2020 | 17174 | 0.130 |
Why?
|
Lung Diseases, Interstitial | 2 | 2017 | 944 | 0.130 |
Why?
|
Organometallic Compounds | 1 | 2019 | 648 | 0.130 |
Why?
|
Monoclonal Gammopathy of Undetermined Significance | 1 | 2017 | 179 | 0.130 |
Why?
|
Nanofibers | 1 | 2015 | 68 | 0.120 |
Why?
|
Saphenous Vein | 1 | 2018 | 519 | 0.120 |
Why?
|
Xenograft Model Antitumor Assays | 7 | 2020 | 3621 | 0.120 |
Why?
|
Iodide Peroxidase | 1 | 2017 | 295 | 0.120 |
Why?
|
Triiodothyronine | 1 | 2017 | 492 | 0.120 |
Why?
|
Vascular Endothelial Growth Factor C | 1 | 2015 | 125 | 0.120 |
Why?
|
Mitral Valve Stenosis | 1 | 2017 | 342 | 0.120 |
Why?
|
Vascular Endothelial Growth Factor Receptor-3 | 1 | 2015 | 118 | 0.120 |
Why?
|
Stomach | 1 | 2019 | 702 | 0.120 |
Why?
|
Immunocompromised Host | 1 | 2020 | 865 | 0.120 |
Why?
|
Glucocorticoids | 1 | 2024 | 2167 | 0.120 |
Why?
|
Carcinoma, Bronchogenic | 1 | 2015 | 86 | 0.120 |
Why?
|
Liver Diseases | 1 | 2023 | 1305 | 0.120 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2020 | 977 | 0.120 |
Why?
|
Graft Survival | 5 | 2015 | 3888 | 0.120 |
Why?
|
Immunohistochemistry | 12 | 2015 | 11119 | 0.120 |
Why?
|
Mice, Inbred C57BL | 15 | 2024 | 22381 | 0.120 |
Why?
|
Safety | 1 | 2019 | 1159 | 0.120 |
Why?
|
Heart Atria | 2 | 2019 | 1360 | 0.120 |
Why?
|
Immunoglobulin Light Chains | 1 | 2015 | 289 | 0.110 |
Why?
|
Antineoplastic Agents | 9 | 2015 | 13699 | 0.110 |
Why?
|
Lymphangiogenesis | 1 | 2015 | 171 | 0.110 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2011 | 1246 | 0.110 |
Why?
|
Bone Marrow | 1 | 2024 | 2935 | 0.110 |
Why?
|
Brain Edema | 1 | 2018 | 607 | 0.110 |
Why?
|
Ethylene Glycols | 1 | 2015 | 198 | 0.110 |
Why?
|
Chondrocytes | 4 | 2008 | 800 | 0.110 |
Why?
|
Hypertrophy | 1 | 2016 | 562 | 0.110 |
Why?
|
Mice, Transgenic | 13 | 2017 | 9564 | 0.110 |
Why?
|
Embolism | 1 | 2017 | 401 | 0.110 |
Why?
|
Receptor Protein-Tyrosine Kinases | 2 | 2010 | 1629 | 0.110 |
Why?
|
Anhydrides | 2 | 2004 | 29 | 0.110 |
Why?
|
Myocardial Reperfusion | 1 | 2015 | 339 | 0.110 |
Why?
|
Risk Factors | 11 | 2024 | 74971 | 0.110 |
Why?
|
Isolated Noncompaction of the Ventricular Myocardium | 1 | 2013 | 22 | 0.110 |
Why?
|
Smad1 Protein | 1 | 2013 | 81 | 0.110 |
Why?
|
Thyroxine | 1 | 2017 | 665 | 0.110 |
Why?
|
Quinazolines | 3 | 2009 | 1373 | 0.110 |
Why?
|
Child, Preschool | 7 | 2022 | 42684 | 0.110 |
Why?
|
Electrocardiography | 6 | 2017 | 6413 | 0.100 |
Why?
|
Inflammation | 6 | 2023 | 10869 | 0.100 |
Why?
|
Foreign Bodies | 1 | 2017 | 403 | 0.100 |
Why?
|
Disease Models, Animal | 12 | 2020 | 18366 | 0.100 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2019 | 2297 | 0.100 |
Why?
|
Retrospective Studies | 16 | 2024 | 81892 | 0.100 |
Why?
|
Transplantation Tolerance | 2 | 2008 | 633 | 0.100 |
Why?
|
Microspheres | 2 | 2006 | 789 | 0.100 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1469 | 0.100 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2017 | 752 | 0.100 |
Why?
|
Pulmonary Valve Stenosis | 1 | 2013 | 164 | 0.100 |
Why?
|
Membrane Proteins | 4 | 2015 | 7885 | 0.100 |
Why?
|
Glutarates | 1 | 2014 | 243 | 0.100 |
Why?
|
Aortic Valve Stenosis | 2 | 2015 | 2034 | 0.100 |
Why?
|
Tissue Adhesives | 1 | 2014 | 179 | 0.100 |
Why?
|
Heparin | 1 | 1999 | 1636 | 0.100 |
Why?
|
Genes, ras | 4 | 2008 | 665 | 0.100 |
Why?
|
Thromboembolism | 1 | 2018 | 1004 | 0.100 |
Why?
|
Capillaries | 1 | 2015 | 756 | 0.100 |
Why?
|
Angiogenesis Inhibitors | 2 | 2014 | 2059 | 0.100 |
Why?
|
Myeloproliferative Disorders | 1 | 2018 | 616 | 0.100 |
Why?
|
Infant, Newborn | 6 | 2018 | 26394 | 0.100 |
Why?
|
Contractile Proteins | 1 | 2012 | 240 | 0.100 |
Why?
|
Mice, Inbred BALB C | 7 | 2015 | 6232 | 0.100 |
Why?
|
Pulmonary Embolism | 2 | 2024 | 2598 | 0.090 |
Why?
|
Transplantation | 1 | 2013 | 221 | 0.090 |
Why?
|
Bronchiolitis Obliterans | 1 | 2013 | 221 | 0.090 |
Why?
|
Infant | 8 | 2022 | 36541 | 0.090 |
Why?
|
Adolescent | 11 | 2024 | 89247 | 0.090 |
Why?
|
Costello Syndrome | 1 | 2011 | 19 | 0.090 |
Why?
|
Tumor Escape | 1 | 2014 | 372 | 0.090 |
Why?
|
Cardiac Imaging Techniques | 1 | 2013 | 281 | 0.090 |
Why?
|
Bioreactors | 3 | 2008 | 246 | 0.090 |
Why?
|
Databases, Factual | 2 | 2024 | 8095 | 0.090 |
Why?
|
Mice, Nude | 6 | 2016 | 3631 | 0.090 |
Why?
|
High-Energy Shock Waves | 1 | 2011 | 33 | 0.090 |
Why?
|
Peritoneum | 2 | 2016 | 231 | 0.090 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2018 | 1942 | 0.090 |
Why?
|
Parvovirus B19, Human | 1 | 2010 | 42 | 0.090 |
Why?
|
Antibodies, Blocking | 3 | 2010 | 250 | 0.090 |
Why?
|
Osteoarthritis | 1 | 2018 | 1070 | 0.090 |
Why?
|
Histological Techniques | 1 | 2011 | 194 | 0.090 |
Why?
|
Protein-Lysine 6-Oxidase | 1 | 2010 | 56 | 0.090 |
Why?
|
Magnetic Resonance Imaging | 8 | 2019 | 36861 | 0.090 |
Why?
|
Cells, Cultured | 12 | 2019 | 19023 | 0.090 |
Why?
|
Myocardial Stunning | 1 | 2010 | 67 | 0.090 |
Why?
|
Heme Oxygenase-1 | 1 | 2013 | 364 | 0.090 |
Why?
|
Periosteum | 1 | 2011 | 139 | 0.090 |
Why?
|
Cell Proliferation | 8 | 2018 | 10486 | 0.090 |
Why?
|
Chromosome Disorders | 1 | 2013 | 499 | 0.090 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 4 | 2017 | 5434 | 0.090 |
Why?
|
Child | 11 | 2022 | 80969 | 0.090 |
Why?
|
Liposomes | 1 | 2014 | 792 | 0.090 |
Why?
|
Pharmaceutical Vehicles | 2 | 2012 | 56 | 0.090 |
Why?
|
Cardiovascular Abnormalities | 1 | 2011 | 148 | 0.090 |
Why?
|
Microvessels | 1 | 2014 | 586 | 0.080 |
Why?
|
Implants, Experimental | 2 | 2012 | 99 | 0.080 |
Why?
|
Central Nervous System | 1 | 2017 | 1345 | 0.080 |
Why?
|
Sarcomeres | 1 | 2012 | 380 | 0.080 |
Why?
|
Th1 Cells | 2 | 2012 | 1042 | 0.080 |
Why?
|
Aniline Compounds | 1 | 2015 | 1094 | 0.080 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 3 | 2016 | 395 | 0.080 |
Why?
|
Myocytes, Cardiac | 3 | 2019 | 1682 | 0.080 |
Why?
|
Time Factors | 10 | 2019 | 40266 | 0.080 |
Why?
|
Knee Prosthesis | 1 | 2012 | 395 | 0.080 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 2 | 2010 | 637 | 0.080 |
Why?
|
Carotid Arteries | 1 | 2014 | 943 | 0.080 |
Why?
|
Cisplatin | 1 | 2015 | 1661 | 0.080 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2014 | 755 | 0.080 |
Why?
|
Brain Death | 1 | 2012 | 359 | 0.080 |
Why?
|
Diphtheria Toxin | 2 | 2007 | 253 | 0.080 |
Why?
|
Carboplatin | 2 | 2010 | 799 | 0.080 |
Why?
|
Cross-Linking Reagents | 2 | 2019 | 692 | 0.080 |
Why?
|
Cyclooxygenase 2 | 1 | 2011 | 599 | 0.080 |
Why?
|
Endothelial Cells | 5 | 2021 | 3591 | 0.080 |
Why?
|
Waldenstrom Macroglobulinemia | 1 | 2018 | 1077 | 0.080 |
Why?
|
Bacteremia | 2 | 2013 | 985 | 0.080 |
Why?
|
Lactic Acid | 2 | 2006 | 1140 | 0.080 |
Why?
|
Silicates | 1 | 2008 | 49 | 0.080 |
Why?
|
MAP Kinase Signaling System | 3 | 2011 | 1494 | 0.080 |
Why?
|
T-Lymphocyte Subsets | 2 | 2022 | 1813 | 0.080 |
Why?
|
Carcinoma, Adenosquamous | 1 | 2009 | 67 | 0.080 |
Why?
|
Decanoates | 1 | 2008 | 55 | 0.080 |
Why?
|
Stroke | 2 | 2023 | 9756 | 0.080 |
Why?
|
Endothelium, Vascular | 3 | 2014 | 4428 | 0.080 |
Why?
|
Neoplasm Metastasis | 4 | 2012 | 4926 | 0.080 |
Why?
|
Gadolinium DTPA | 1 | 2012 | 823 | 0.080 |
Why?
|
Breast Implants | 1 | 2012 | 414 | 0.080 |
Why?
|
Janus Kinase 2 | 2 | 2024 | 560 | 0.080 |
Why?
|
Myosin-Light-Chain Kinase | 1 | 2008 | 104 | 0.080 |
Why?
|
Esophageal Neoplasms | 1 | 2018 | 1674 | 0.080 |
Why?
|
Swine | 2 | 2019 | 5998 | 0.080 |
Why?
|
Sequence Analysis, DNA | 1 | 2019 | 4784 | 0.080 |
Why?
|
PTEN Phosphohydrolase | 1 | 2014 | 1120 | 0.080 |
Why?
|
Cardiovascular Diseases | 3 | 2022 | 15662 | 0.080 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2013 | 847 | 0.080 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2012 | 282 | 0.080 |
Why?
|
Postoperative Complications | 5 | 2018 | 15889 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2012 | 567 | 0.070 |
Why?
|
Sepsis | 2 | 2013 | 2609 | 0.070 |
Why?
|
Diagnosis, Differential | 7 | 2019 | 13020 | 0.070 |
Why?
|
Sensitivity and Specificity | 6 | 2019 | 14751 | 0.070 |
Why?
|
Albumins | 1 | 2010 | 577 | 0.070 |
Why?
|
Ventricular Function, Left | 2 | 2018 | 3941 | 0.070 |
Why?
|
Heart Block | 1 | 2009 | 390 | 0.070 |
Why?
|
Mitral Valve Insufficiency | 1 | 2017 | 1415 | 0.070 |
Why?
|
Acrylamides | 1 | 2009 | 261 | 0.070 |
Why?
|
Receptor, erbB-2 | 2 | 2009 | 2606 | 0.070 |
Why?
|
Cell Differentiation | 7 | 2011 | 11684 | 0.070 |
Why?
|
Microscopy, Electron, Scanning | 5 | 2010 | 945 | 0.070 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2013 | 507 | 0.070 |
Why?
|
Mice, Knockout | 7 | 2024 | 14485 | 0.070 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2014 | 958 | 0.070 |
Why?
|
Medical Oncology | 1 | 2019 | 2350 | 0.070 |
Why?
|
Glycerol | 1 | 2008 | 274 | 0.070 |
Why?
|
MAP Kinase Kinase 2 | 1 | 2007 | 93 | 0.070 |
Why?
|
Kidney | 2 | 2021 | 7057 | 0.070 |
Why?
|
Sirolimus | 3 | 2009 | 1540 | 0.070 |
Why?
|
Receptors, Virus | 1 | 2010 | 652 | 0.070 |
Why?
|
AMP-Activated Protein Kinases | 4 | 2014 | 598 | 0.070 |
Why?
|
Feedback, Physiological | 1 | 2009 | 481 | 0.070 |
Why?
|
Myoblasts | 1 | 2008 | 234 | 0.070 |
Why?
|
Bronchial Neoplasms | 1 | 2007 | 111 | 0.070 |
Why?
|
Immunoconjugates | 4 | 2012 | 976 | 0.070 |
Why?
|
Liver | 2 | 2021 | 7579 | 0.070 |
Why?
|
Drug Resistance, Neoplasm | 4 | 2009 | 5342 | 0.070 |
Why?
|
S100 Proteins | 1 | 2007 | 217 | 0.070 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 2 | 2010 | 1143 | 0.070 |
Why?
|
Magnetics | 1 | 2009 | 599 | 0.070 |
Why?
|
Hip Prosthesis | 1 | 2012 | 924 | 0.070 |
Why?
|
Neoplasms, Experimental | 2 | 2018 | 1231 | 0.070 |
Why?
|
Polyesters | 2 | 2018 | 377 | 0.070 |
Why?
|
Tissue Donors | 2 | 2015 | 2382 | 0.070 |
Why?
|
Extracellular Matrix Proteins | 1 | 2010 | 835 | 0.070 |
Why?
|
Protein Kinase Inhibitors | 4 | 2012 | 5707 | 0.070 |
Why?
|
Specimen Handling | 1 | 2011 | 708 | 0.070 |
Why?
|
Hematologic Neoplasms | 1 | 2018 | 1907 | 0.070 |
Why?
|
Bone Marrow Cells | 3 | 2013 | 2414 | 0.060 |
Why?
|
Immunotherapy | 2 | 2019 | 4755 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 6 | 2021 | 20776 | 0.060 |
Why?
|
ras Proteins | 1 | 2011 | 1058 | 0.060 |
Why?
|
Neovascularization, Pathologic | 2 | 2013 | 2634 | 0.060 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2007 | 331 | 0.060 |
Why?
|
Organ Culture Techniques | 1 | 2008 | 796 | 0.060 |
Why?
|
Mice, Mutant Strains | 4 | 2010 | 1755 | 0.060 |
Why?
|
Thiazolidinediones | 1 | 2008 | 461 | 0.060 |
Why?
|
Cell Communication | 1 | 2012 | 1660 | 0.060 |
Why?
|
Respiration, Artificial | 1 | 2017 | 2724 | 0.060 |
Why?
|
Nitric Oxide | 1 | 2014 | 2149 | 0.060 |
Why?
|
Leukemia Inhibitory Factor Receptor alpha Subunit | 1 | 2024 | 30 | 0.060 |
Why?
|
Metal Nanoparticles | 1 | 2009 | 406 | 0.060 |
Why?
|
Acrylic Resins | 2 | 2019 | 135 | 0.060 |
Why?
|
11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2024 | 29 | 0.060 |
Why?
|
Connective Tissue | 2 | 2005 | 425 | 0.060 |
Why?
|
Transforming Growth Factor beta | 2 | 2011 | 2004 | 0.060 |
Why?
|
Chromosome Mapping | 1 | 2013 | 4624 | 0.060 |
Why?
|
Recurrence | 5 | 2015 | 8512 | 0.060 |
Why?
|
Neurodegenerative Diseases | 1 | 2014 | 1094 | 0.060 |
Why?
|
Peptides | 2 | 2007 | 4353 | 0.060 |
Why?
|
Polyglycolic Acid | 1 | 2006 | 408 | 0.060 |
Why?
|
Viral Load | 3 | 2021 | 3398 | 0.060 |
Why?
|
Antigens, CD1 | 1 | 2007 | 434 | 0.060 |
Why?
|
Echocardiography, Doppler, Color | 2 | 2017 | 353 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2019 | 10778 | 0.060 |
Why?
|
Fractures, Spontaneous | 1 | 2006 | 232 | 0.060 |
Why?
|
Pandemics | 5 | 2023 | 8745 | 0.060 |
Why?
|
Heart Valves | 1 | 2006 | 284 | 0.060 |
Why?
|
Patella | 1 | 2006 | 317 | 0.060 |
Why?
|
Dextrans | 1 | 2006 | 574 | 0.060 |
Why?
|
Blood Vessels | 2 | 2002 | 1110 | 0.060 |
Why?
|
Mammals | 1 | 2009 | 1136 | 0.060 |
Why?
|
Epithelium | 1 | 2008 | 1607 | 0.060 |
Why?
|
Immunoglobulin D | 1 | 2023 | 55 | 0.050 |
Why?
|
Neutrophils | 2 | 2014 | 3785 | 0.050 |
Why?
|
Nanostructures | 1 | 2008 | 553 | 0.050 |
Why?
|
Disease Progression | 5 | 2024 | 13677 | 0.050 |
Why?
|
Models, Chemical | 2 | 2009 | 611 | 0.050 |
Why?
|
Muscle Proteins | 1 | 2008 | 1165 | 0.050 |
Why?
|
Pyrimidines | 2 | 2018 | 3050 | 0.050 |
Why?
|
Prognosis | 3 | 2019 | 30044 | 0.050 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2012 | 1335 | 0.050 |
Why?
|
Receptors, CXCR5 | 1 | 2023 | 88 | 0.050 |
Why?
|
Epinephrine | 1 | 2006 | 794 | 0.050 |
Why?
|
Prostatic Hyperplasia | 1 | 2007 | 523 | 0.050 |
Why?
|
Metaplasia | 2 | 2015 | 326 | 0.050 |
Why?
|
Perfusion | 1 | 2008 | 1402 | 0.050 |
Why?
|
Hydrogels | 3 | 2019 | 745 | 0.050 |
Why?
|
Coronary Vessels | 1 | 2014 | 3124 | 0.050 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2010 | 2884 | 0.050 |
Why?
|
Bacterial Infections | 1 | 2011 | 1397 | 0.050 |
Why?
|
Pyrroles | 1 | 2009 | 1126 | 0.050 |
Why?
|
Kinetics | 3 | 2018 | 6334 | 0.050 |
Why?
|
Penile Induration | 1 | 2002 | 17 | 0.050 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2010 | 1616 | 0.050 |
Why?
|
Phenotype | 4 | 2019 | 16735 | 0.050 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2010 | 627 | 0.050 |
Why?
|
Mesenchymal Stem Cells | 1 | 2013 | 1672 | 0.050 |
Why?
|
Europe | 3 | 2015 | 3441 | 0.050 |
Why?
|
Adipogenesis | 1 | 2024 | 371 | 0.050 |
Why?
|
Mutagenesis, Site-Directed | 2 | 2008 | 1683 | 0.050 |
Why?
|
Benzothiazoles | 1 | 2022 | 248 | 0.050 |
Why?
|
Bone Remodeling | 1 | 2005 | 583 | 0.050 |
Why?
|
Treatment Outcome | 8 | 2021 | 65485 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2020 | 4593 | 0.050 |
Why?
|
Vitamin D | 1 | 2015 | 3311 | 0.050 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2024 | 4356 | 0.050 |
Why?
|
Carbon | 1 | 2005 | 672 | 0.050 |
Why?
|
Feasibility Studies | 3 | 2021 | 5323 | 0.050 |
Why?
|
Age Distribution | 2 | 2018 | 2875 | 0.050 |
Why?
|
Biomedical Engineering | 2 | 2001 | 286 | 0.050 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2012 | 3411 | 0.050 |
Why?
|
Indoles | 1 | 2009 | 1836 | 0.040 |
Why?
|
Composite Resins | 1 | 2000 | 72 | 0.040 |
Why?
|
Interleukin-4 | 1 | 2024 | 1157 | 0.040 |
Why?
|
Death, Sudden, Cardiac | 2 | 2022 | 1568 | 0.040 |
Why?
|
Risk Assessment | 2 | 2019 | 24330 | 0.040 |
Why?
|
Gene Transfer Techniques | 2 | 2002 | 1209 | 0.040 |
Why?
|
Prospective Studies | 7 | 2021 | 54950 | 0.040 |
Why?
|
Penile Neoplasms | 1 | 2002 | 158 | 0.040 |
Why?
|
Dexamethasone | 2 | 2005 | 1965 | 0.040 |
Why?
|
Public Policy | 1 | 2024 | 552 | 0.040 |
Why?
|
Membrane Glycoproteins | 2 | 2009 | 3714 | 0.040 |
Why?
|
Cell Membrane Permeability | 2 | 2012 | 573 | 0.040 |
Why?
|
Growth Substances | 1 | 2002 | 760 | 0.040 |
Why?
|
Imaging, Three-Dimensional | 1 | 2013 | 4077 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2023 | 9442 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2011 | 3518 | 0.040 |
Why?
|
Antigens, Differentiation | 1 | 2003 | 921 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2020 | 190 | 0.040 |
Why?
|
Membrane Lipids | 1 | 2021 | 252 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2021 | 3814 | 0.040 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2023 | 465 | 0.040 |
Why?
|
Tumor Burden | 2 | 2020 | 1913 | 0.040 |
Why?
|
World Health Organization | 2 | 2021 | 1327 | 0.040 |
Why?
|
Atlases as Topic | 1 | 2021 | 248 | 0.040 |
Why?
|
Reproducibility of Results | 5 | 2019 | 20244 | 0.040 |
Why?
|
Hemangiosarcoma | 1 | 2002 | 215 | 0.040 |
Why?
|
Desiccation | 1 | 2019 | 77 | 0.040 |
Why?
|
Membrane Fusion | 1 | 2021 | 265 | 0.040 |
Why?
|
Case-Control Studies | 4 | 2021 | 22294 | 0.040 |
Why?
|
Phagocytes | 1 | 2021 | 294 | 0.040 |
Why?
|
Hydrogen Bonding | 1 | 2019 | 290 | 0.040 |
Why?
|
Molecular Weight | 2 | 2015 | 2173 | 0.040 |
Why?
|
Elasticity | 2 | 2014 | 657 | 0.040 |
Why?
|
Methotrexate | 1 | 2006 | 1723 | 0.040 |
Why?
|
Arthritis | 1 | 2024 | 684 | 0.040 |
Why?
|
Injections | 2 | 2014 | 841 | 0.040 |
Why?
|
Static Electricity | 1 | 2019 | 261 | 0.040 |
Why?
|
Gout | 1 | 2006 | 621 | 0.040 |
Why?
|
Osteophyte | 1 | 2018 | 44 | 0.040 |
Why?
|
Hypertrophy, Left Ventricular | 2 | 2014 | 856 | 0.040 |
Why?
|
Communicable Diseases | 1 | 2007 | 873 | 0.040 |
Why?
|
Societies, Medical | 1 | 2011 | 3967 | 0.040 |
Why?
|
Dendrimers | 1 | 2018 | 73 | 0.040 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2010 | 2831 | 0.040 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2014 | 4064 | 0.040 |
Why?
|
Arrhythmias, Cardiac | 2 | 2023 | 2258 | 0.040 |
Why?
|
DNA | 2 | 2009 | 7214 | 0.040 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 1999 | 259 | 0.040 |
Why?
|
Microscopy, Confocal | 3 | 2012 | 1973 | 0.040 |
Why?
|
Pulmonary Alveoli | 1 | 2021 | 665 | 0.040 |
Why?
|
Chitosan | 1 | 2019 | 141 | 0.040 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2011 | 3116 | 0.040 |
Why?
|
Particle Size | 3 | 2008 | 1652 | 0.040 |
Why?
|
Megakaryocytes | 1 | 2022 | 571 | 0.040 |
Why?
|
Technetium | 1 | 2018 | 326 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2008 | 8664 | 0.040 |
Why?
|
Gelatin | 1 | 2019 | 231 | 0.040 |
Why?
|
Follow-Up Studies | 5 | 2019 | 39394 | 0.040 |
Why?
|
Immunoglobulin lambda-Chains | 1 | 2017 | 83 | 0.040 |
Why?
|
Coronary Circulation | 2 | 2014 | 1617 | 0.040 |
Why?
|
Human Growth Hormone | 1 | 2002 | 648 | 0.040 |
Why?
|
Enzyme Inhibitors | 1 | 2008 | 3724 | 0.040 |
Why?
|
Prevalence | 4 | 2017 | 15875 | 0.040 |
Why?
|
Death Certificates | 1 | 2018 | 172 | 0.040 |
Why?
|
Succinic Acid | 1 | 2018 | 86 | 0.040 |
Why?
|
Pericarditis | 1 | 2019 | 136 | 0.040 |
Why?
|
Ventricular Dysfunction, Left | 3 | 2014 | 2145 | 0.040 |
Why?
|
Hypotension | 2 | 2013 | 888 | 0.040 |
Why?
|
Amyloid | 1 | 2022 | 854 | 0.040 |
Why?
|
Cell Hypoxia | 2 | 2010 | 662 | 0.040 |
Why?
|
Antibodies, Monoclonal | 4 | 2008 | 9264 | 0.040 |
Why?
|
Prostate-Specific Antigen | 1 | 2007 | 2487 | 0.040 |
Why?
|
MicroRNAs | 1 | 2013 | 3811 | 0.040 |
Why?
|
Equipment Contamination | 1 | 2018 | 183 | 0.040 |
Why?
|
Lactates | 1 | 1998 | 401 | 0.040 |
Why?
|
Hydrolases | 1 | 2018 | 146 | 0.040 |
Why?
|
STAT Transcription Factors | 1 | 2018 | 189 | 0.040 |
Why?
|
Immunoglobulin kappa-Chains | 1 | 2017 | 171 | 0.040 |
Why?
|
Interferon-alpha | 1 | 2021 | 910 | 0.040 |
Why?
|
Peptide Fragments | 2 | 2007 | 5150 | 0.040 |
Why?
|
NIH 3T3 Cells | 2 | 2009 | 669 | 0.040 |
Why?
|
Phosphorylation | 4 | 2009 | 8317 | 0.040 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2007 | 2059 | 0.040 |
Why?
|
Serologic Tests | 1 | 2019 | 383 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2021 | 1342 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2009 | 11886 | 0.030 |
Why?
|
Joints | 1 | 2018 | 324 | 0.030 |
Why?
|
Brazil | 1 | 2021 | 1249 | 0.030 |
Why?
|
Ultrasonography | 3 | 2015 | 6001 | 0.030 |
Why?
|
Flow Cytometry | 3 | 2012 | 5905 | 0.030 |
Why?
|
Janus Kinases | 1 | 2018 | 253 | 0.030 |
Why?
|
Respiratory System | 1 | 2020 | 565 | 0.030 |
Why?
|
Stromal Cells | 2 | 2001 | 1337 | 0.030 |
Why?
|
Osteoblasts | 1 | 2002 | 1153 | 0.030 |
Why?
|
Organ Specificity | 1 | 2021 | 1970 | 0.030 |
Why?
|
In Situ Nick-End Labeling | 2 | 2007 | 612 | 0.030 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2017 | 330 | 0.030 |
Why?
|
Administration, Inhalation | 1 | 2019 | 1169 | 0.030 |
Why?
|
DNA-Binding Proteins | 1 | 2013 | 9618 | 0.030 |
Why?
|
Indocyanine Green | 1 | 2017 | 239 | 0.030 |
Why?
|
Survival Rate | 3 | 2015 | 12873 | 0.030 |
Why?
|
Molecular Structure | 3 | 2006 | 1885 | 0.030 |
Why?
|
United States | 6 | 2024 | 73180 | 0.030 |
Why?
|
Hypoglycemic Agents | 1 | 2008 | 3110 | 0.030 |
Why?
|
Cellulose | 1 | 1996 | 117 | 0.030 |
Why?
|
Porosity | 2 | 2008 | 352 | 0.030 |
Why?
|
Collagen | 3 | 2014 | 2646 | 0.030 |
Why?
|
Tissue Embedding | 1 | 2015 | 43 | 0.030 |
Why?
|
Cancer Vaccines | 1 | 2003 | 1042 | 0.030 |
Why?
|
Cytokines | 3 | 2021 | 7453 | 0.030 |
Why?
|
Neoplasm Transplantation | 2 | 2012 | 2018 | 0.030 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2002 | 1658 | 0.030 |
Why?
|
Gentamicins | 1 | 2016 | 244 | 0.030 |
Why?
|
Bronchoscopy | 1 | 2021 | 914 | 0.030 |
Why?
|
DNA Primers | 2 | 2012 | 2827 | 0.030 |
Why?
|
Syndrome | 1 | 2021 | 3274 | 0.030 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2022 | 1803 | 0.030 |
Why?
|
Drug Interactions | 1 | 1999 | 1421 | 0.030 |
Why?
|
Moraxellaceae Infections | 1 | 2014 | 7 | 0.030 |
Why?
|
Th2 Cells | 2 | 2012 | 1079 | 0.030 |
Why?
|
Emergencies | 1 | 2021 | 1220 | 0.030 |
Why?
|
Vasculitis | 1 | 2019 | 525 | 0.030 |
Why?
|
Skin | 1 | 2008 | 4507 | 0.030 |
Why?
|
Autoradiography | 1 | 2015 | 732 | 0.030 |
Why?
|
Keratin-15 | 1 | 2014 | 22 | 0.030 |
Why?
|
Propionibacterium acnes | 1 | 2014 | 59 | 0.030 |
Why?
|
Receptor, Nerve Growth Factor | 1 | 2014 | 48 | 0.030 |
Why?
|
Keratin-5 | 1 | 2014 | 43 | 0.030 |
Why?
|
Gene Expression Profiling | 4 | 2014 | 9549 | 0.030 |
Why?
|
Spleen | 1 | 2020 | 2294 | 0.030 |
Why?
|
Combined Modality Therapy | 2 | 2020 | 8559 | 0.030 |
Why?
|
Pneumonia | 1 | 2006 | 2163 | 0.030 |
Why?
|
B-Lymphocytes | 2 | 2020 | 4794 | 0.030 |
Why?
|
Exons | 2 | 2013 | 2395 | 0.030 |
Why?
|
Alkaline Phosphatase | 2 | 2011 | 864 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2009 | 1339 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2011 | 9081 | 0.030 |
Why?
|
Radionuclide Imaging | 1 | 2018 | 1998 | 0.030 |
Why?
|
Orthopedics | 1 | 2003 | 906 | 0.030 |
Why?
|
Electrochemical Techniques | 1 | 2014 | 95 | 0.030 |
Why?
|
Cell Line | 3 | 2014 | 15603 | 0.030 |
Why?
|
Tumor Cells, Cultured | 2 | 2014 | 6131 | 0.030 |
Why?
|
Vasomotor System | 1 | 2014 | 208 | 0.030 |
Why?
|
Comorbidity | 2 | 2021 | 10591 | 0.030 |
Why?
|
Chondrogenesis | 2 | 2005 | 239 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2011 | 7460 | 0.030 |
Why?
|
Boston | 2 | 2017 | 9375 | 0.030 |
Why?
|
Rubidium Radioisotopes | 1 | 2013 | 97 | 0.030 |
Why?
|
Transcription Factors | 1 | 2013 | 12174 | 0.030 |
Why?
|
Tensile Strength | 1 | 2014 | 335 | 0.030 |
Why?
|
Water | 1 | 2019 | 1421 | 0.030 |
Why?
|
Brain | 1 | 2020 | 27476 | 0.030 |
Why?
|
Macrophages | 3 | 2014 | 5800 | 0.030 |
Why?
|
Protein Binding | 2 | 2015 | 9344 | 0.030 |
Why?
|
Immunoglobulin M | 1 | 2018 | 1528 | 0.030 |
Why?
|
Photochemistry | 2 | 2004 | 238 | 0.030 |
Why?
|
Drug Design | 2 | 2010 | 1046 | 0.030 |
Why?
|
Hyperemia | 1 | 2014 | 224 | 0.030 |
Why?
|
Antigens, Ly | 1 | 2014 | 296 | 0.030 |
Why?
|
Diffusion | 2 | 2005 | 818 | 0.030 |
Why?
|
Nitriles | 1 | 2018 | 990 | 0.030 |
Why?
|
Membranes | 1 | 2012 | 164 | 0.030 |
Why?
|
RNA | 1 | 2022 | 2727 | 0.030 |
Why?
|
Gastrointestinal Tract | 1 | 2018 | 839 | 0.030 |
Why?
|
RNA, Viral | 1 | 2021 | 2871 | 0.030 |
Why?
|
Up-Regulation | 1 | 2021 | 4148 | 0.030 |
Why?
|
Models, Animal | 2 | 2010 | 2123 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2013 | 6546 | 0.030 |
Why?
|
SOXB1 Transcription Factors | 1 | 2014 | 286 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2012 | 2574 | 0.030 |
Why?
|
Sus scrofa | 1 | 2014 | 430 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2018 | 2525 | 0.020 |
Why?
|
Cecum | 1 | 2013 | 231 | 0.020 |
Why?
|
Echocardiography | 2 | 2018 | 5046 | 0.020 |
Why?
|
Regeneration | 1 | 2021 | 1524 | 0.020 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2012 | 2433 | 0.020 |
Why?
|
Durapatite | 1 | 2013 | 167 | 0.020 |
Why?
|
Enzyme Activation | 2 | 2009 | 3588 | 0.020 |
Why?
|
Comparative Genomic Hybridization | 1 | 2013 | 474 | 0.020 |
Why?
|
Cholesterol | 1 | 2021 | 2913 | 0.020 |
Why?
|
Zebrafish | 2 | 2013 | 3037 | 0.020 |
Why?
|
Neoplasm Invasiveness | 2 | 2010 | 3629 | 0.020 |
Why?
|
Polymyalgia Rheumatica | 1 | 2011 | 52 | 0.020 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2014 | 342 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2022 | 4651 | 0.020 |
Why?
|
Iatrogenic Disease | 1 | 2015 | 552 | 0.020 |
Why?
|
Enzyme-Linked Immunospot Assay | 1 | 2011 | 126 | 0.020 |
Why?
|
Hemolysis | 1 | 2013 | 417 | 0.020 |
Why?
|
Lymph Node Excision | 1 | 2017 | 1273 | 0.020 |
Why?
|
Organ Preservation | 1 | 2015 | 394 | 0.020 |
Why?
|
Surgical Mesh | 1 | 2014 | 316 | 0.020 |
Why?
|
Frameshift Mutation | 1 | 2013 | 393 | 0.020 |
Why?
|
Lymphatic Vessels | 1 | 2015 | 356 | 0.020 |
Why?
|
Cardiovascular System | 1 | 2018 | 840 | 0.020 |
Why?
|
Blood | 1 | 2014 | 597 | 0.020 |
Why?
|
Quinolines | 2 | 2007 | 772 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2016 | 2488 | 0.020 |
Why?
|
Postmortem Changes | 1 | 2011 | 119 | 0.020 |
Why?
|
Apoptosis | 4 | 2008 | 9528 | 0.020 |
Why?
|
Collagen Type III | 1 | 2011 | 92 | 0.020 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2013 | 640 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2015 | 12093 | 0.020 |
Why?
|
Parvoviridae Infections | 1 | 2010 | 39 | 0.020 |
Why?
|
Caco-2 Cells | 1 | 2011 | 365 | 0.020 |
Why?
|
Antilymphocyte Serum | 1 | 2012 | 492 | 0.020 |
Why?
|
Coronary Angiography | 2 | 2015 | 4541 | 0.020 |
Why?
|
Prednisone | 1 | 2015 | 1567 | 0.020 |
Why?
|
Binding Sites | 1 | 1999 | 6023 | 0.020 |
Why?
|
Chronic Disease | 2 | 2021 | 9384 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2018 | 2204 | 0.020 |
Why?
|
Fluoroscopy | 1 | 2015 | 947 | 0.020 |
Why?
|
Dihydroxyacetone | 1 | 2010 | 8 | 0.020 |
Why?
|
Polycarboxylate Cement | 1 | 2010 | 18 | 0.020 |
Why?
|
Blood Flow Velocity | 1 | 2014 | 1376 | 0.020 |
Why?
|
Osteocalcin | 1 | 2011 | 277 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2010 | 2063 | 0.020 |
Why?
|
Forced Expiratory Volume | 1 | 2015 | 1832 | 0.020 |
Why?
|
Image Enhancement | 2 | 2012 | 2898 | 0.020 |
Why?
|
Transplantation Immunology | 1 | 2012 | 537 | 0.020 |
Why?
|
Escherichia coli Infections | 1 | 2014 | 524 | 0.020 |
Why?
|
Seroma | 1 | 2010 | 74 | 0.020 |
Why?
|
Subtraction Technique | 1 | 2013 | 519 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2017 | 15471 | 0.020 |
Why?
|
Pilot Projects | 2 | 2019 | 8742 | 0.020 |
Why?
|
Epididymal Secretory Proteins | 1 | 2009 | 12 | 0.020 |
Why?
|
Sex Distribution | 1 | 2015 | 2280 | 0.020 |
Why?
|
Membrane Transport Proteins | 1 | 2015 | 1039 | 0.020 |
Why?
|
Models, Biological | 2 | 2012 | 9499 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2017 | 2916 | 0.020 |
Why?
|
Proteomics | 1 | 2023 | 3913 | 0.020 |
Why?
|
Rats, Wistar | 1 | 2014 | 1890 | 0.020 |
Why?
|
Breast Implantation | 1 | 2012 | 225 | 0.020 |
Why?
|
Algorithms | 1 | 2010 | 14199 | 0.020 |
Why?
|
Fluorescent Dyes | 1 | 2017 | 1933 | 0.020 |
Why?
|
beta-Defensins | 1 | 2009 | 60 | 0.020 |
Why?
|
North America | 1 | 2013 | 1290 | 0.020 |
Why?
|
Cohort Studies | 3 | 2018 | 41800 | 0.020 |
Why?
|
Organic Cation Transport Proteins | 1 | 2009 | 61 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2542 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2015 | 2931 | 0.020 |
Why?
|
Surface Properties | 2 | 2005 | 1169 | 0.020 |
Why?
|
Immunoglobulins | 1 | 2012 | 855 | 0.020 |
Why?
|
Interleukin-10 | 1 | 2015 | 1184 | 0.020 |
Why?
|
Peritonitis | 1 | 2011 | 368 | 0.020 |
Why?
|
Immunosuppressive Agents | 2 | 2015 | 4207 | 0.020 |
Why?
|
Fluorescein | 1 | 2009 | 175 | 0.020 |
Why?
|
Computer Graphics | 1 | 2011 | 344 | 0.020 |
Why?
|
Ileum | 1 | 2011 | 558 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2021 | 3701 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2024 | 26384 | 0.020 |
Why?
|
Heart Function Tests | 1 | 2009 | 317 | 0.020 |
Why?
|
Uteroglobin | 1 | 2008 | 56 | 0.020 |
Why?
|
Ultraviolet Rays | 1 | 2014 | 1104 | 0.020 |
Why?
|
Polycythemia | 1 | 2009 | 124 | 0.020 |
Why?
|
Embryonic Development | 1 | 2013 | 724 | 0.020 |
Why?
|
Chromosome Deletion | 1 | 2013 | 1390 | 0.020 |
Why?
|
Staining and Labeling | 1 | 2012 | 1081 | 0.020 |
Why?
|
Gels | 1 | 2009 | 422 | 0.020 |
Why?
|
Elastomers | 1 | 2008 | 69 | 0.020 |
Why?
|
Base Sequence | 2 | 2012 | 12430 | 0.020 |
Why?
|
X-Ray Microtomography | 1 | 2010 | 457 | 0.020 |
Why?
|
Survival | 1 | 2008 | 160 | 0.020 |
Why?
|
Preoperative Period | 1 | 2010 | 565 | 0.020 |
Why?
|
Contrast Media | 2 | 2012 | 5334 | 0.020 |
Why?
|
Hospitals, Pediatric | 1 | 2017 | 1876 | 0.020 |
Why?
|
Age Factors | 2 | 2017 | 18454 | 0.020 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2015 | 1724 | 0.020 |
Why?
|
Myocardial Contraction | 1 | 2013 | 1526 | 0.020 |
Why?
|
Reference Values | 1 | 2015 | 4941 | 0.020 |
Why?
|
Cell Movement | 3 | 2011 | 5216 | 0.020 |
Why?
|
Neoplasm Staging | 2 | 2017 | 11262 | 0.020 |
Why?
|
Sheep | 1 | 2010 | 1451 | 0.020 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2009 | 304 | 0.020 |
Why?
|
GPI-Linked Proteins | 1 | 2009 | 472 | 0.020 |
Why?
|
Radiation Chimera | 1 | 2007 | 216 | 0.020 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2013 | 672 | 0.020 |
Why?
|
Genetic Vectors | 2 | 2009 | 3414 | 0.020 |
Why?
|
Pyrazoles | 1 | 2018 | 2029 | 0.020 |
Why?
|
Survival Analysis | 2 | 2010 | 10115 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2017 | 6856 | 0.020 |
Why?
|
Lymphocyte Culture Test, Mixed | 1 | 2007 | 510 | 0.020 |
Why?
|
Motion | 1 | 2011 | 794 | 0.020 |
Why?
|
H-2 Antigens | 1 | 2007 | 359 | 0.020 |
Why?
|
Syncope | 1 | 2010 | 430 | 0.020 |
Why?
|
von Willebrand Factor | 1 | 2011 | 680 | 0.020 |
Why?
|
Prostatic Neoplasms | 2 | 2007 | 11229 | 0.020 |
Why?
|
Phagocytosis | 1 | 2013 | 1530 | 0.020 |
Why?
|
Genes, p16 | 1 | 2007 | 159 | 0.020 |
Why?
|
Injections, Subcutaneous | 1 | 2008 | 687 | 0.020 |
Why?
|
Metabolome | 1 | 2014 | 1009 | 0.020 |
Why?
|
Promoter Regions, Genetic | 2 | 2009 | 5801 | 0.020 |
Why?
|
Cell Count | 1 | 2011 | 1833 | 0.020 |
Why?
|
Aging | 1 | 2006 | 8765 | 0.020 |
Why?
|
Endothelium | 1 | 2009 | 768 | 0.020 |
Why?
|
Cardiomegaly | 1 | 2009 | 591 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2018 | 1886 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2015 | 6242 | 0.020 |
Why?
|
Mitochondria | 2 | 2010 | 3683 | 0.020 |
Why?
|
Connective Tissue Cells | 1 | 2006 | 50 | 0.020 |
Why?
|
Ethanol | 1 | 2012 | 1332 | 0.020 |
Why?
|
Esters | 1 | 2007 | 212 | 0.020 |
Why?
|
Mesoderm | 1 | 2009 | 679 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2015 | 2431 | 0.020 |
Why?
|
Anti-Bacterial Agents | 2 | 2016 | 7472 | 0.020 |
Why?
|
Systems Integration | 1 | 2008 | 430 | 0.020 |
Why?
|
Lymphocyte Depletion | 1 | 2008 | 605 | 0.020 |
Why?
|
Carbohydrate Sequence | 1 | 2006 | 411 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2010 | 17629 | 0.020 |
Why?
|
PPAR gamma | 1 | 2008 | 487 | 0.020 |
Why?
|
Genes, Neoplasm | 1 | 2007 | 371 | 0.020 |
Why?
|
Excipients | 1 | 2005 | 98 | 0.020 |
Why?
|
Postoperative Period | 1 | 2010 | 1830 | 0.020 |
Why?
|
Gene Targeting | 1 | 2008 | 841 | 0.020 |
Why?
|
Sterilization | 1 | 2006 | 132 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2015 | 2813 | 0.020 |
Why?
|
Equipment Failure Analysis | 1 | 2008 | 848 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2012 | 21187 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2014 | 2452 | 0.020 |
Why?
|
Tibia | 1 | 2011 | 1076 | 0.020 |
Why?
|
Doxycycline | 1 | 2007 | 349 | 0.020 |
Why?
|
Fibrillar Collagens | 1 | 2005 | 42 | 0.020 |
Why?
|
Linear Models | 1 | 2015 | 5890 | 0.020 |
Why?
|
Genes, p53 | 1 | 2007 | 716 | 0.020 |
Why?
|
Immune Tolerance | 1 | 2014 | 2323 | 0.020 |
Why?
|
Cell Separation | 1 | 2010 | 1728 | 0.010 |
Why?
|
Acute Disease | 1 | 2015 | 7245 | 0.010 |
Why?
|
Killer Cells, Natural | 1 | 2014 | 2211 | 0.010 |
Why?
|
Wound Healing | 1 | 2016 | 2815 | 0.010 |
Why?
|
Antibodies | 1 | 2013 | 2422 | 0.010 |
Why?
|
Femur | 1 | 2011 | 1320 | 0.010 |
Why?
|
User-Computer Interface | 1 | 2011 | 1406 | 0.010 |
Why?
|
Elastin | 1 | 2006 | 299 | 0.010 |
Why?
|
Trans-Activators | 1 | 2014 | 2858 | 0.010 |
Why?
|
Pressure | 1 | 2008 | 1172 | 0.010 |
Why?
|
Respiration | 1 | 2011 | 1668 | 0.010 |
Why?
|
Melanoma | 1 | 2003 | 5709 | 0.010 |
Why?
|
Preoperative Care | 1 | 2013 | 2258 | 0.010 |
Why?
|
Silicon | 1 | 2005 | 143 | 0.010 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2008 | 906 | 0.010 |
Why?
|
DNA, Recombinant | 1 | 2004 | 455 | 0.010 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2007 | 410 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2012 | 3163 | 0.010 |
Why?
|
Mutation, Missense | 1 | 2013 | 2592 | 0.010 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2006 | 462 | 0.010 |
Why?
|
Ki-67 Antigen | 1 | 2006 | 628 | 0.010 |
Why?
|
DNA, Viral | 1 | 2010 | 2205 | 0.010 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2006 | 761 | 0.010 |
Why?
|
Massachusetts | 1 | 2017 | 8888 | 0.010 |
Why?
|
Carbohydrates | 1 | 2005 | 389 | 0.010 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2007 | 710 | 0.010 |
Why?
|
Macrophages, Alveolar | 1 | 2006 | 415 | 0.010 |
Why?
|
Injections, Intramuscular | 1 | 2005 | 556 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2010 | 2730 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 8055 | 0.010 |
Why?
|
Stress, Mechanical | 1 | 2008 | 1680 | 0.010 |
Why?
|
Genetic Engineering | 1 | 2009 | 936 | 0.010 |
Why?
|
Respiratory Tract Infections | 1 | 2011 | 1014 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2008 | 2695 | 0.010 |
Why?
|
Stents | 1 | 2015 | 3200 | 0.010 |
Why?
|
Genes, Tumor Suppressor | 1 | 2007 | 1064 | 0.010 |
Why?
|
Spectrum Analysis, Raman | 1 | 2005 | 253 | 0.010 |
Why?
|
Temperature | 1 | 2009 | 2235 | 0.010 |
Why?
|
Cytodiagnosis | 1 | 2006 | 453 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2014 | 3613 | 0.010 |
Why?
|
Mechanotransduction, Cellular | 1 | 2008 | 542 | 0.010 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2006 | 633 | 0.010 |
Why?
|
Adrenal Cortex Hormones | 1 | 2011 | 1893 | 0.010 |
Why?
|
Critical Care | 1 | 2015 | 2715 | 0.010 |
Why?
|
Skin Transplantation | 1 | 2007 | 1097 | 0.010 |
Why?
|
Plasmids | 1 | 2007 | 2269 | 0.010 |
Why?
|
Escherichia coli | 1 | 2014 | 4212 | 0.010 |
Why?
|
Risk | 1 | 2014 | 9621 | 0.010 |
Why?
|
Mastectomy | 1 | 2010 | 1850 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2021 | 12798 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2007 | 2862 | 0.010 |
Why?
|
Blotting, Western | 1 | 2009 | 5035 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2011 | 6512 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 2006 | 1627 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 2005 | 2560 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2011 | 2747 | 0.010 |
Why?
|
Down-Regulation | 1 | 2008 | 2941 | 0.010 |
Why?
|
Benzamides | 1 | 2007 | 1387 | 0.010 |
Why?
|
Protein Kinases | 1 | 2008 | 1611 | 0.010 |
Why?
|
Subcutaneous Tissue | 1 | 2002 | 131 | 0.010 |
Why?
|
Glycerophosphates | 1 | 2001 | 51 | 0.010 |
Why?
|
Microscopy, Fluorescence | 2 | 1998 | 2635 | 0.010 |
Why?
|
Length of Stay | 1 | 2015 | 6525 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2017 | 14795 | 0.010 |
Why?
|
Mice, SCID | 1 | 2006 | 2631 | 0.010 |
Why?
|
Blotting, Northern | 1 | 2002 | 1553 | 0.010 |
Why?
|
Culture Techniques | 1 | 2001 | 530 | 0.010 |
Why?
|
Acute Coronary Syndrome | 1 | 2013 | 2194 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2010 | 3233 | 0.010 |
Why?
|
Registries | 1 | 2017 | 8384 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2014 | 7609 | 0.010 |
Why?
|
Calcification, Physiologic | 1 | 2000 | 171 | 0.010 |
Why?
|
Intestine, Small | 1 | 2006 | 1218 | 0.010 |
Why?
|
Models, Molecular | 1 | 2009 | 5404 | 0.010 |
Why?
|
Equipment Design | 1 | 2008 | 3529 | 0.010 |
Why?
|
Stroke Volume | 1 | 2013 | 5621 | 0.010 |
Why?
|
Range of Motion, Articular | 1 | 2006 | 1599 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2006 | 3775 | 0.010 |
Why?
|
Adaptation, Physiological | 1 | 2006 | 1315 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2002 | 1990 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2010 | 13427 | 0.010 |
Why?
|
Genes, Reporter | 1 | 2002 | 1524 | 0.010 |
Why?
|
Glycosaminoglycans | 1 | 2001 | 611 | 0.010 |
Why?
|
Necrosis | 1 | 2003 | 1621 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2005 | 3102 | 0.010 |
Why?
|
Fetus | 1 | 2006 | 1882 | 0.010 |
Why?
|
PC12 Cells | 1 | 1998 | 317 | 0.010 |
Why?
|
Biodegradation, Environmental | 1 | 1998 | 220 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2008 | 6320 | 0.010 |
Why?
|
Computer Simulation | 1 | 2012 | 6289 | 0.010 |
Why?
|
Fluorescein-5-isothiocyanate | 1 | 1998 | 222 | 0.010 |
Why?
|
Microscopy, Atomic Force | 1 | 1998 | 250 | 0.010 |
Why?
|
Biotinylation | 1 | 1998 | 185 | 0.010 |
Why?
|
Smoking | 1 | 2015 | 9094 | 0.010 |
Why?
|
Antigen Presentation | 1 | 2003 | 1252 | 0.010 |
Why?
|
Knee Joint | 1 | 2006 | 1685 | 0.010 |
Why?
|
Skull | 1 | 2002 | 830 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2012 | 12809 | 0.010 |
Why?
|
Gestational Age | 1 | 2006 | 3610 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2011 | 3538 | 0.010 |
Why?
|
Transfection | 1 | 2004 | 5763 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2015 | 5892 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2004 | 2395 | 0.010 |
Why?
|
Chick Embryo | 1 | 1998 | 975 | 0.010 |
Why?
|
Anti-Inflammatory Agents | 1 | 2005 | 1813 | 0.010 |
Why?
|
Radiography | 1 | 2006 | 6991 | 0.010 |
Why?
|
Lipids | 1 | 2005 | 3345 | 0.010 |
Why?
|
Weight Loss | 1 | 2006 | 2720 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2013 | 11521 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2004 | 3608 | 0.010 |
Why?
|
Proteins | 1 | 2005 | 6011 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 1998 | 1667 | 0.010 |
Why?
|
Cell Division | 1 | 1998 | 4478 | 0.010 |
Why?
|
Coronary Artery Disease | 1 | 2010 | 6569 | 0.010 |
Why?
|
Insulin | 1 | 2001 | 6610 | 0.000 |
Why?
|
Stem Cells | 1 | 1998 | 3540 | 0.000 |
Why?
|